[Management of climacteric disorders using a new combination drug Menrium].
D001008:Anxiety Disorders / Q000188:drug therapy; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D002979:Climacteric / Q000187:drug effects*; D003863:Depression / Q000188:drug therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D012893:Sleep Wake Disorders / Q000188:drug therapy; D013610:Tachycardia / Q000188:drug therapy
D004966:Estrogens, Conjugated (USP); D002707:Chlordiazepoxide
Die Behandlung klimakterischer Beschwerden mit dem neuen Kombinationspräparat Menrium.